Works matching IS 00099236 AND DT 2025 AND VI 117 AND IP 3


Results: 30
    1
    2
    3

    Highlighted Articles.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 612, doi. 10.1002/cpt.3548
    Publication type:
    Article
    4
    5
    6

    ASCPT News.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 614, doi. 10.1002/cpt.3551
    Publication type:
    Article
    7

    In This Issue.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 607, doi. 10.1002/cpt.3550
    Publication type:
    Article
    8
    9
    11
    12
    13

    Trends of Publication of Negative Trials Over Time.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 818, doi. 10.1002/cpt.3535
    By:
    • Laviolle, Bruno;
    • Locher, Clara;
    • Allain, Jean‐Sébastien;
    • Le Cornu, Quentin;
    • Charpentier, Pierre;
    • Lefebvre, Marie;
    • Le Pape, Clémence;
    • Leven, Cyril;
    • Palpacuer, Clément;
    • Pontoizeau, Clémence;
    • Bellissant, Eric;
    • Naudet, Florian
    Publication type:
    Article
    14
    15
    16
    17

    Population Pharmacokinetic/Pharmacodynamic and Exposure‐Response Modeling Analyses of Sotatercept in Healthy Participants and Patients with Pulmonary Arterial Hypertension.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 798, doi. 10.1002/cpt.3524
    By:
    • Ait‐Oudhia, Sihem;
    • Jaworowicz, David;
    • Hu, Ziheng;
    • Gaurav, Mitali;
    • Barcomb, Heather;
    • Hu, Shuai;
    • Bihorel, Sébastien;
    • Balasubrahmanyam, Budda;
    • Mistry, Bipin;
    • de Oliveira Pena, Janethe;
    • Wenning, Larissa;
    • Gheyas, Ferdous
    Publication type:
    Article
    18
    19
    20

    Safety, Pharmacokinetics, and Pharmacodynamics of a First‐in‐Class ClC‐1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 768, doi. 10.1002/cpt.3516
    By:
    • Ruijs, Titia Q.;
    • de Cuba, Catherine M. K. E.;
    • Heuberger, Jules A. A. C.;
    • Hutchison, John;
    • Bold, Jane;
    • Grønnebæk, Thomas S.;
    • Jensen, Klaus G.;
    • Chin, Eva;
    • Quiroz, Jorge A.;
    • Petersen, Thomas K.;
    • Flagstad, Peter;
    • de Kam, Marieke L.;
    • van Esdonk, Michiel J.;
    • Klaassen, Erica;
    • Doll, Robert J.;
    • Koopmans, Ingrid W.;
    • de Goede, Annika A.;
    • Aulin, Linda B. S.;
    • Pedersen, Thomas H.;
    • Groeneveld, Geert Jan
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28

    A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 716, doi. 10.1002/cpt.3504
    By:
    • So, Gerald C.;
    • Lu, Jessica Bo Li;
    • Koyama, Sachiko;
    • Cheng, Ying‐Hua;
    • Gisch, Debora L.;
    • McClara, Kelsey;
    • Dexter, Paul R.;
    • Sharfuddin, Asif A.;
    • Etkins, Jumar;
    • Tillman, Emma M.;
    • Beamon, Travis R.;
    • Cowsert, Zachary;
    • Stuart, Jennifer S.;
    • Desta, Zeruesenay;
    • Eadon, Michael T.
    Publication type:
    Article
    29
    30

    Issue Information.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 599, doi. 10.1002/cpt.3319
    Publication type:
    Article